Summary
Abivax SA is a French clinical-stage, publicly traded biotechnology company harnessing the immune system to develop novel treatments against inflammatory diseases, viral diseases and cancer.
Deals Overview
Senior Management
Marc de Garidel
CEO
Didier Blondel
CFO
All rights reserved. Copyright © 2025 Datasite